Summary

Snoring is caused by resistance and turbulence in the upper airway. When the muscles are at their most relaxed, they keep the upper airway open during REM sleep or dream sleep. Air turbulence increases as the airway narrows, causing the soft tissues in the back of the throat to vibrate. Furthermore, as more people become aware of the health risks associated with snoring, such as sleep apnea, high blood pressure, and cardiovascular disease, the demand for anti-snoring devices has increased. Moreover, anti-snoring devices are a non-invasive treatment option for snoring and sleep apnea that is increasingly preferred over surgical options. Furthermore, the use of anti-snoring devices is supported by many medical professionals in Europe as a safe and effective way to treat snoring and mild to moderate sleep apnea. In addition to anti-snoring devices, lifestyle changes such as weight loss, quitting smoking, and avoiding alcohol before bedtime are also recommended to reduce snoring and sleep apnea.

According to the research report, "Europe Anti Snoring Device Market Outlook, 2028", published by Bonafide Research, the Europe Anti Snoring Device market is expected to grow at more than 7.5% CAGR from 2023 to 2028. As the population in Europe ages, the prevalence of snoring and sleep apnea is expected to increase, which will drive the demand for anti-snoring devices. Furthermore, obesity is a known risk factor for sleep apnea, and the high prevalence of obesity in Europe has led to an increase in the number of people diagnosed with sleep apnea. This has driven the demand for anti-snoring devices as a non-surgical treatment option. Moreover, home sleep apnea testing allows patients to test for sleep apnea in the comfort of their own homes, without the need to visit a sleep center. This has increased the demand for anti-snoring devices as a non-invasive treatment option for patients diagnosed with mild to moderate sleep apnea. In addition, governments in Europe are taking initiatives to improve public health by increasing awareness about the health risks of snoring and sleep apnea, which is driving the demand for anti-snoring devices.

Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. Among them, In the Europe market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy.

The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Among them, Hospitals have the largest market share among the various types of anti-snoring and sleep apnea devices. Hospitals are the primary channel for the distribution of sleep apnea devices in Europe, as they are the primary source of diagnosis and treatment for sleep-disordered breathing. Hospitals offer a range of diagnostic tests, including polysomnography, which is used to diagnose sleep apnea and other sleep disorders. After diagnosis, hospitals often prescribe and dispense anti-snoring and sleep apnea devices to patients. E-commerce is expected to grow at a higher CAGR during the forecast period. One of the main drivers of the growth in e-commerce for anti-snoring and sleep apnea devices is the increasing popularity of online shopping among consumers. Many consumers prefer the convenience and accessibility of online shopping, particularly for products that are often viewed as personal or sensitive, such as anti-snoring and sleep apnea devices.

According to the report, the Europe market is segmented into three major countries, including Germany, United Kingdom, France, Italy, Spain, and Russia. Among these, the Germany leads the Europe Anti-Snoring Device market. The most common type of anti-snoring device used in Germany is the mandibular advancement device (MAD), which is worn like a mouthguard to keep the airway open during sleep. Furthermore, German medical professionals often recommend anti-snoring devices as a safe and effective way to treat snoring and mild to moderate sleep apnea. Moreover, the German market for anti-snoring devices is competitive, with many companies offering a wide range of devices at different price points. In addition, technological advancements such as the use of 3D printing and other innovative materials have led to the development of more effective and comfortable anti-snoring devices, which has contributed to the growth of the anti-snoring device market in Germany.

During the middle Ages, European physicians recommended various remedies for snoring, including drinking boiled onions mixed with wine or wearing a metal chain around the neck. Furthermore, in the 1980s, German researchers developed the first continuous positive airway pressure (CPAP) machine, which uses a mask and air pressure to keep the airway open during sleep. CPAP is now widely used as a treatment for sleep apnea. Moreover, in the 19th century, physicians began to experiment with more advanced anti-snoring devices, such as nose clips and metal splints, which were designed to keep the airway open during sleep. In addition, the first mandibular advancement device (MAD) was invented in France in 1902 by Pierre Robin, a dentist. The device, which was worn like a mouthguard, was designed to push the lower jaw forward and keep the airway open during sleep.

There are several manufacturers of anti-snoring devices in Europe. Some notable ones are ResMed, which is a global leader in sleep apnea treatment and has a range of anti-snoring devices such as CPAP machines, nasal masks, and oral masks. Furthermore, Philips Respironics is a leading manufacturer of sleep therapy devices and offers a range of anti-snoring devices such as CPAP machines, nasal masks, and oral masks. Moreover, SomnoMed is a manufacturer of oral appliances for the treatment of snoring and sleep apnea. Furthermore, Air Liquide Healthcare offers a range of anti-snoring devices such as CPAP machines, nasal masks, and oral masks. In addition, NightBalance is a manufacturer of positional therapy devices for the treatment of snoring and sleep apnea.

Europe is a popular destination for medical tourism, and sleep clinics and centers are no exception. This presents an opportunity for manufacturers and retailers to market their products to medical tourists who are seeking effective treatments for snoring and sleep apnea. Furthermore, manufacturers and retailers can partner with healthcare providers, such as sleep clinics and hospitals, to promote their anti-snoring devices. This can help increase brand visibility and build trust among consumers. Moreover, the regulatory environment in Europe is favorable for the anti-snoring device market, with stringent regulations that ensure the safety and efficacy of medical devices. This presents an opportunity for manufacturers to develop high-quality and reliable anti-snoring devices that meet regulatory requirements.

Restraints:
Anti-snoring devices can be expensive, which may limit their affordability and accessibility for some consumers. The high cost may also deter some consumers from seeking treatment for snoring and sleep apnea. Furthermore, in some European countries, anti-snoring devices are not covered by health insurance or reimbursement schemes. This may limit the demand for these devices among consumers who cannot afford them out-of-pocket. Moreover, some consumers may prefer natural remedies over medical devices, such as lifestyle changes, herbal supplements, or home remedies. This may limit the demand for anti-snoring devices and make it more difficult for manufacturers and retailers to succeed in this market.

Start-ups:
• Snoreeze is a UK-based start-up that specializes in anti-snoring products, including nasal sprays, oral strips, and mouthpieces. The company's products are designed to help reduce snoring by opening up the airways and promoting better breathing during sleep.
• Sleep.ai is a Netherlands-based start-up that has developed a smart anti-snoring device. The device uses advanced algorithms and sensors to detect snoring and adjust the user's sleeping position to help reduce snoring and improve sleep quality.
• Somnox is a Netherlands-based start-up that has developed a sleep robot designed to help users fall asleep faster and stay asleep longer. The robot uses a range of features, including breathing regulation, soothing sounds, and gentle movements, to promote relaxation and improve sleep quality.
• QuietOn is a Finland-based start-up that has developed a range of noise-cancelling earplugs designed to help reduce snoring and other disruptive noises during sleep. The earplugs use advanced noise-cancelling technology to block out unwanted sounds and promote better sleep.
• SleepHero is a German-based start-up that has developed a range of anti-snoring products, including nasal strips and mouthpieces. The company's products are designed to help reduce snoring by opening up the airways and promoting better breathing during sleep.

Developments:
• In 2021, Philips launched a new range of anti-snoring devices, including a smart sleep band and a nasal pillow mask. The devices use advanced algorithms to detect snoring and adjust pressure levels to help users breathe more comfortably.
• ResMed introduced a new anti-snoring device in 2021 called the AirSense 10 AutoSet. The device uses advanced algorithms to detect snoring and automatically adjusts air pressure levels to help users breathe more comfortably.
• SleepTight launched a new anti-snoring device in 2021 called the SleepTight Mouthpiece. The device is designed to help keep the airway open during sleep by holding the lower jaw in a forward position.
• SnoreMeds introduced a new anti-snoring device in 2021 called the SnoreMeds Mouthpiece. The device is designed to help keep the airway open by holding the lower jaw in a forward position and can be customized to fit individual users.
• Silentnight launched a new range of anti-snoring pillows in 2021. The pillows are designed to help reduce snoring by keeping the head and neck in a comfortable position and promoting better breathing during sleep.

Companies Mentioned in this Report:
Koninklijke Philips N.V., LivaNova PLC, Fisher & Paykel Healthcare Corporation Limited., SomnoMed Inc, Medtronic plc, Meditas Ltd., ResMed Inc., GlaxoSmithKline plc, ZQuiet LLC, Mpowrx, Nyxoah SA, Whole You, Inc.

Considered in this report
• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report
• Europe Anti Snoring Device market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Countries covered in the report:
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product Type:
• Mandibular Advancement Device
• Nasal Device
• Position Control Device
• Chin Straps
• EPAP/CPAP
• Tongue Stabilizing

By Distribution Chanel:
• Hospitals
• Clinics
• Retail Pharmacies
• E-commerce
• Others

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, government-generated reports, and databases. After gathering the data from secondary sources, primary research was conducted by making telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started doing primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations and organizations related to the Anti Snoring Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents